Plus Disease

Survey of Ophthalmology

Volumn 54, Issue 6, 2009, Pages 663-670

  Davitt, Bradley V ^a   Wallace, David K ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ETROP; ICROP; plus disease; pre plus disease; prematurity; retinopathy; ROPtool; threshold

Indexed keywords

VASCULOTROPIN;

CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED RADIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; MEDICAL DECISION MAKING; OPHTHALMOSCOPY; PATHOPHYSIOLOGY; PLUS DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA DISEASE; RETROLENTAL FIBROPLASIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

HUMANS; INFANT, NEWBORN; LASER COAGULATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINAL VESSELS; RETINOPATHY OF PREMATURITY;

EID: 70349778860     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.02.021     Document Type: Review

References (50)

1. Ahmad S., Wallace D.K., Freedman S.F., and Zhao Z. Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images. Retina 28 (2008) 1458-1462
2. Aylward S.R., and Bullitt E. Initialization, noise, singularities, and scale in height ridge traversal for tubular object centerline extraction. IEEE Trans Med Imaging 21 (2002) 61-75
3. Baum J.D. Retinal artery tortuosity in ex-premature infants: 18-year follow-up on eyes of premature infants. Arch Dis Child 46 (1971) 247-252
4. Capowski J.J., Kylstra J.A., and Freedman S.F. A numerical index based on spatial frequency for the tortuosity of retinal vessels and its application to plus disease in retinopathy of prematurity. Retina 15 6 (1995) 490-500
5. Chiang M.F., Jiang L., Gelman R., et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 125 7 (2007) 875-880
6. Coats D.K. Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention. Trans Am Ophthalmol Soc 103 (2005) 281-312
7. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Arch Ophthalmol 112 7 (1994) 903-912
8. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 106 4 (1988) 471-479
9. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121 12 (2003) 1684-1694
10. Fielder A.R. Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121 12 (2003) 1769-1770
11. Fielder A.R., Shaw D.E., Robinson J., and Ng Y.K. Natural history of retinopathy of prematurity: a prospective study. Eye 6 Pt 3 (1992) 233-242
12. Fielder A.R., and Wilkinson A.R. The further refinement of ROP treatment. commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age. Br J Ophthalmol 91 2 (2007) 136-137
13. Flynn J.T., O'Grady G.E., Herrera J., et al. Retrolental fibro-plasia: I. Clinical observations. Arch Ophthalmol 95 2 (1977) 217-223
14. Freedman S.F., Kylstra J.A., Capowski J.J., et al. Observer sensitivity to retinal vessel diameter and tortuosity in retinopathy of prematurity: a model system. J Pediatr Ophthalmol Strabismus 33 4 (1996) 248-254
15. Freedman S.F., Kylstra J.A., Hall J.G., and Capowski J.J. Plus disease in retinopathy of prematurity-photographic evaluation by an expert panel (abstract). Invest Ophthalmol Vis Sci 36 (1995) 76
16. Gelman R., Jiang L., Du Y.E., et al. Plus disease in retinopathy of prematurity: pilot study of computer-based and expert diagnosis. J AAPOS 11 6 (2007) 532-540
17. Gelman R., Martinez-Perez M.E., Vanderveen D.K., et al. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci 46 12 (2005) 4734-4738
18. Hartnett M.E., and McColm J.R. Retinal features predictive of progressive stage 4 retinopathy of prematurity. Retina 24 2 (2004) 237-241
19. Hartnett M.E., Martiniuk D., Byfield G., et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci 49 7 (2008) 3107-3114
20. Heneghan C., Flynn J., O'Keefe M., and Cahill M. Characterization of changes in blood vessel width and tortuosity in retinopathy of prematurity using image analysis. Medical Image Analysis 6 4 (2002) 407-429
21. Hix IE. A review of retrolental fibroplasia, with an analysis of the fundoscopic appearance as an aid to prognosis. M.S. Thesis, University of Colorado, 1953
22. Ho M., Hsu H.T., Rich K.A., et al. Differences in retinal angiogenic response to sustained intravitreal release of VEGF and bFGF between different breeds of rabbits. IOVS 41 4 (2000) 518
23. Holland D.R., Saunders R.A., Kagemann L.E., et al. Color doppler imaging of the central retinal artery in premature infants undergoing examination for retinopathy of prematurity. J AAPOS 3 4 (1999) 194-198
24. Hughes S., Gardiner T., Baxter L., and Chan-Ling T. Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease. Inv Ophthalmol Vis Sci 48 (2007) 1368-1379
25. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123 7 (2005) 991-999
26. Johnston S.C., Wallace D.K., Freedman S.F., et al. Tortuosity of Arterioles and Venules in Quantifying Plus Disease. J AAPOS 2 (2009) 181-185
27. Keegan S.J., Mills M.D., Karp K.A., and Grunwald J.E. Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. AJO 143 4 (2007) 723-725
28. Kingham J.D. Acute retrolental fibroplasia. Arch Ophth 95 (1977) 39-47
29. Koreen S., Gelman R., Martinez-Perez M.E., et al. Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology 114 12 (2007) e59-e67
30. Owens W.C., and Owens E.U. Retrolental fibroplasia in premature infants. Am J Ophthalmol 32 (1949) 1-21
31. Palmer E.A., Flynn J.T., Hardy R.J., et al. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology 98 11 (1991) 1628-1640
32. Patton N., Aslam T.M., MacGillivray T., et al. Retinal image analysis: concepts, applications and potential. Prog Retin Eye Res 25 (2006) 99-127
33. Phelps D.L. It's plus disease, isn't it?. Arch Ophthalmol 125 7 (2007) 963-964
34. Quinn G.E. The dilemma of digital imaging in retinopathy of prematurity. J AAPOS 11 6 (2007) 529-530
35. Quinn G.E., Schaffer D.B., and Johnson L. A revised classification of retinopathy of prematurity. Am J Ophthalmol 94 6 (1982) 744-749
36. Saunders R.A., Bluestein E.C., Berland J.E., et al. Can non-ophthalmologists screen for retinopathy of prematurity?. J Pediatr Ophthalmol Strabismus 32 5 (1995) 302-304
37. Saunders R.A., Bluestein E.C., Sinatra R.B., et al. The predictive value of posterior pole vessels in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 32 12 (1995) 82-85
38. Schaffer D.B., Johnson L., Quinn G.E., and Boggs Jr. T.R. A classification of retrolental fibroplasias to evaluate vitamin E therapy. Ophthalmology 86 (1979) 1749-1760
39. Schaffer D.B., Palmer E.A., Plotsky D.F., et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 100 2 (1993) 230-237
40. Swanson C., Cocker K.D., Parker K.H., et al. Semiautomated computer analysis of vessel growth in preterm infants without and with ROP. Br J Ophthalmol 87 12 (2003) 1474-1477
41. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 102 8 (1984) 1130-1134
42. The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105 2 (2000) 295-310
43. Uemura Y. Current status of retrolental fibroplasia: report of the joint committee for the study of retrolental fibroplasia in Japan. Jpn J Ophthalmol 21 (1977) 366-378
44. Wallace DK, Freedman SF, Zhao Z. A Pilot study using ROPtool to measure retinal dilation. Retina. 2009 May 27. [Epub ahead of print]
45. Wallace D.K., Freedman S.F., Zhao Z., and Jung S.H. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 125 11 (2007) 1523-1530
46. Wallace D.K., Jomier J., Aylward S.R., and Landers III M.B. Computer-automated quantification of plus disease in retinopathy of prematurity. J AAPOS 7 2 (2003) 126-130
47. Wallace D.K., Kylstra J.A., and Chesnutt D.A. Prognostic significance of vascular dilation and tortuosity insufficient for plus disease in retinopathy of prematurity. J AAPOS 4 4 (2000) 224-229
48. Wallace D.K., Quinn G.E., Freedman S.F., and Chiang M.F. Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS 12 (2008) 352-356
49. Wallace D.K., Zhao Z., and Freedman S.F. A pilot study using "ROPTool" to quantify plus disease in retinopathy of prematurity. J AAPOS 11 4 (2007) 381-387
50. Wilson C.M., Cocker K.D., Moseley M.J., et al. Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest Ophthalmol Vis Sci 49 (2008) 3577-3585